9-86945938-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002048.3(GAS1):āc.842A>Gā(p.Glu281Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,589,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002048.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GAS1 | NM_002048.3 | c.842A>G | p.Glu281Gly | missense_variant | 1/1 | ENST00000298743.9 | NP_002039.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GAS1 | ENST00000298743.9 | c.842A>G | p.Glu281Gly | missense_variant | 1/1 | 6 | NM_002048.3 | ENSP00000298743.7 |
Frequencies
GnomAD3 genomes AF: 0.000119 AC: 18AN: 151764Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000119 AC: 24AN: 201704Hom.: 0 AF XY: 0.000125 AC XY: 14AN XY: 111832
GnomAD4 exome AF: 0.000147 AC: 211AN: 1438234Hom.: 0 Cov.: 32 AF XY: 0.000165 AC XY: 118AN XY: 713946
GnomAD4 genome AF: 0.000119 AC: 18AN: 151764Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74110
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 281 of the GAS1 protein (p.Glu281Gly). This variant is present in population databases (rs749020654, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with GAS1-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at